Detalhe da pesquisa
1.
Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia.
BMC Vet Res
; 13(1): 294, 2017 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28969639
2.
A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
BMC Vet Res
; 12(1): 257, 2016 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27855679
3.
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
BMC Vet Res
; 11: 131, 2015 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26062540
4.
Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose.
BMC Vet Res
; 9: 190, 2013 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24079884
5.
Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma: A Review Based on a Consensus Organized by the Brazilian Association of Veterinary Oncology, ABROVET.
Cancers (Basel)
; 15(7)2023 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046686
6.
Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
BMC Vet Res
; 12(1): 291, 2016 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28038672
7.
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
PLoS One
; 10(4): e0124889, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25923466